-
-
Categories
-
1-2 of 2
Bevacizumab versus Ranibizumab — The Verdict
Explore The New England Journal of Medicine (Apr 28 2011) Journal Articles , AMD , Retina
For 5 years, patients and clinicians have wrestled with the choice between two drugs for the treatment of neovascular age-related macular degeneration (AMD), a common cause of irreversible blindness among the elderly worldwide. (Read Full Article)
Comment Mentions: Bascom Palmer Eye Institute Genentech
Poppers-Associated Retinal Toxicity
Explore The New England Journal of Medicine (Oct 13 2010) Case Reports , Journal Articles
Here, we describe four patients who were seen within a few months of one another and who had prolonged visual loss as a result of damage to foveal photoreceptors shortly after inhaling poppers. (Read Full Article)
1-2 of 2



Recent Comments
Eye on OCT » Contact Us
Zeiss is investigating a range of technologies for the future.
Romar » Contact Us
I would like to know what you think about Swept-Source OCT in glaucoma and if ...
See all recent comments